Patients With ALS and Other Motor Disorders Will be Treated With Umbilical or Placental Mesenchymal Cell Exosome Solution

Study Identifier:
FOREM2024EX01
ClinicalTrials.gov Identifier:
NCT07105371
EudraCT Identifier:
N/A
EU CT Number:
N/A
Sponsor:
The Foundation for Orthopaedics and Regenerative Medicine
Study Complete

Study Details

Medical Condition
    Study Drug
    • Biological: Exosome Secretome
    Date
    Jul 2024 - May 2026
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    Patient Requirements
    Sex: Female & Male
    Age: 18+ years
    Requirements Information
    Inclusion and Exclusion Criteria
    Inclusion Criteria
    • Patients will need a diagnosis established by a neurologist. Patients must be able to provide informed consent, or have a guardian who does. They must be able to travel to the site of treatment.
    Exclusion Criteria
    • Patients were excluded from the trial if they were pregnant or had active cancer at the screening consultation.

    Protocol Summary

    Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.

    Trial Locations

    Location
    Status
    Location
    Prodromos Stem Cell Institute
    Naples, Florida, United States, 34102
    Status
    N/A
    Location
    Prodromos Stem Cell Institute
    Athens, Greece
    Status
    N/A

    Contact Cure SMA

    User Information

    If you have general questions regarding clinical trials or would like to be added to the Cure SMA mailing list to receive communications regarding future registries, studies, or clinical trials in SMA, please fill out the form below. Fields marked with an asterisk (*) are mandatory.

    • Disability Advocate who does not have SMA
    • I am a healthcare provider
    • I am a researcher
    • I have no direct connection to SMA
    • I have SMA
    • I lost a child to SMA
    • My child has SMA
    • Someone close to me has/had SMA
    • Australia
    • Belgium
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Estonia
    • France
    • Germany
    • Greece
    • Hong Kong
    • Hungary
    • India
    • Ireland
    • Israel
    • Italy
    • Japan
    • Lebanon
    • Malaysia
    • Mexico
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Republic of Korea
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.